Evidence map›Paper›PMID 40871497›Full record

ArticleMolecules (Basel, Switzerland)2025

New 4-(Morpholin-4-Yl)-3-Nitrobenzhydrazide Based Scaffold: Synthesis, Structural Insights, and Biological Evaluation.

Michał Janowski, Sara Janowska, Sylwia Andrzejczuk, Urszula Kosikowska, Radomir Jasiński, Barbara Mirosław, Marcin Feldo, Monika Wujec, Oleg M Demchuk

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michał JanowskiMedical University of Lublin, Doctoral School, 7 Chodzki Str., 20-093 Lublin, Poland.
Sara JanowskaDepartment of Pathobiochemistry and Interdisciplinary Applications of Ion Chromatography, Biomedical Sciences, Medical University of Lublin, 1 Chodzki Str., 20-093 Lublin, Poland.
Sylwia AndrzejczukMedical University of Lublin, Department of Pharmaceutical Microbiology, 1 Chodzki Str., 20-093 Lublin, Poland.ORCID 0000-0001-6301-6059
Urszula KosikowskaMedical University of Lublin, Department of Pharmaceutical Microbiology, 1 Chodzki Str., 20-093 Lublin, Poland.ORCID 0000-0003-4536-1750
Radomir JasińskiCracow University of Technology, Department of Organic Chemistry and Technology, Warszawska 24, 31-155 Cracow, Poland.ORCID 0000-0001-8555-6793
Barbara MirosławMaria Curie-Sklodowska University in Lublin, Department of General and Coordination Chemistry and Crystallography, Institute of Chemical Sciences, Faculty of Chemistry, Maria Curie-Sklodowska sq. 2, 20-031 Lublin, Poland.ORCID 0000-0002-5765-4641
Marcin FeldoMedical University of Lublin, Chair and Department of Vascular Surgery and Angiology, 11 Staszica St., 20-081 Lublin, Poland.
Monika WujecMedical University of Lublin, Department of Organic Chemistry, 4a Chodzki Str., 20-093 Lublin, Poland.ORCID 0000-0001-9816-1934
Oleg M DemchukThe John Paul II Catholic University of Lublin, Faculty of Medicine, Konstantynów 1J, 20-708 Lublin, Poland.ORCID 0000-0002-5571-1593

Funding

Polish National Science Centre 2019/33/B/NZ7/01608
6 · The paper itself

Abstract

The search for new antimicrobial agents is one of the major challenges in contemporary medicinal chemistry due to the global issue of increasing drug resistance. In our efforts to identify chemical structures with antibiotic activity that differ from commonly used antibiotics, we focused our research on (thio)semicarbazides and hydrazones. Guided by literature reports, we designed and synthesized a series of novel semicarbazides, thiosemicarbazides, and hydrazones based on the structure of 4-(morpholino-4-yl)-3-nitrobenzohydrazide. The obtained derivatives were subsequently evaluated in in vitro assays for their activity against reference strains of Gram-positive and Gram-negative bacteria. Among the studied groups of compounds, the semicarbazide derivatives exhibited the highest activity. The most active compound identified in the study was a semicarbazide containing a 4-bromophenyl moiety. This compound showed antibacterial potential against Enterococcus faecalis, with a MIC value of 3.91 µg/mL. Among the thiosemicarbazides, the most active compound contained a 4-trifluoromethylphenyl group, with MIC values against Gram-positive bacterial strains (excluding Staphylococcus aureus) ranging from 31.25 to 62.5 µg/mL. None of the tested hydrazones exhibited antimicrobial activity against the examined bacteria. Additionally, the structures of the new compounds were confirmed by single-crystal X-ray analysis, which enabled the investigation of their properties using advanced quantum chemical calculations.

Indexed as

Anti-Bacterial AgentsSemicarbazidesGram-Negative BacteriaGram-Positive BacteriaHydrazinesHydrazonesMicrobial Sensitivity TestsMolecular StructureStructure-Activity RelationshipAnti-Bacterial AgentsHydrazinesHydrazonesSemicarbazidesantibacterial activityhydrazideshydrazonessemicarbazidesthiosemicarbazides

Identifiers

PMID40871497
PMCPMC12388722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.